{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:51:54Z","timestamp":1764510714847},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,5,15]]},"DOI":"10.2169\/internalmedicine.6386-20","type":"journal-article","created":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T22:09:54Z","timestamp":1607292594000},"page":"1597-1600","source":"Crossref","is-referenced-by-count":5,"title":["Central Nervous System Involvement in Mantle Cell Lymphoma Presenting Magnetic Resonance Imaging Features of Mild Encephalitis\/Encephalopathy with a Reversible Splenial Lesion"],"prefix":"10.2169","volume":"60","author":[{"given":"Makoto","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Hematology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Iwasa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cheah CY, George A, Gin\u00e9 E, et al. Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol 24: 2119-2123, 2013.","DOI":"10.1093\/annonc\/mdt139"},{"key":"2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000144274.12174.CB","volume":"63","author":"H Tada","year":"2004","unstructured":"2. Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis\/encephalopathy with a reversible splenial lesion. Neurology 63: 1854-1858, 2004.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ka A, Britton P, Troedson C, et al. Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis. Eur J Paediatr Neurol 19: 377-382, 2015.","DOI":"10.1016\/j.ejpn.2015.01.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID-19-associated mild encephalitis\/encephalopathy with a reversible splenial lesion. J Neurol Sci 415: 116941, 2020.","DOI":"10.1016\/j.jns.2020.116941"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. van Dongen JJ, Langerak AW, Br\u00fcggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317, 2003.","DOI":"10.1038\/sj.leu.2403202"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miyata R, Tanuma N, Hayashi M, et al. Oxidative stress in patients with clinically mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS). Brain Dev 34: 124-127, 2012.","DOI":"10.1016\/j.braindev.2011.04.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takanashi J, Maeda M, Hayashi M. Neonate showing reversible splenial lesion. Arch Neurol 62: 1481-1482, 2005.","DOI":"10.1001\/archneur.62.9.1481"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Schob S, Meyer J, Gawlitza M, et al. Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma. PLoS One 11: e0161386, 2016.","DOI":"10.1371\/journal.pone.0161386"},{"key":"9","unstructured":"9. Lewis KL, Chin CK, Manos K, et al. Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance\/MD Anderson Cancer Center experience. Br J Haematol. Forthcoming."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Michallet M, Dreger P, Sobh M, et al. Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Bone Marrow Transplant 55: 884-890, 2020.","DOI":"10.1038\/s41409-019-0742-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood 135: 1912-1915, 2020.","DOI":"10.1182\/blood.2020006288"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_6386-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T04:04:40Z","timestamp":1621051480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_6386-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6386-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,15]]}}}